Minerva Neurosciences | NERV - حساب الفائدة على الديون





حساب الفائدة على الديون تغيير تاريخ
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Adma Biologics USD 3.42M 1.32M 2026-06
ALKERMES USD 27.55M 1.63M 2026-09
AstraZeneca USD 371M 31M 2026-09
BioCryst Pharmaceuticals USD 21.71M 7.58M 2026-06
Bristol-Myers Squibb USD 403M 4M 2026-09
Cipla INR 167.4M 2.9M 2026-09
Compugen USD 1.84M 485K 2026-06
CSL USD 215M 111M 2025-12
Eli Lilly USD 316M 201.3M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
Grifols EUR 156.07M 31.46M 2025-09
Halozyme Therapeutics USD 6.04M 457K 2026-09
Ionis Pharmaceuticals USD 18M 1000K 2026-06
J&J USD 43M 25M 2026-03
Merck USD 525M 46M 2026-06
Minerva Neurosciences USD 2.31M 60K 2024-06
Neurocrine Biosciences USD 300K 2.6M 2026-09
Novartis USD 468M 6M 2026-09
Novavax USD 5.82M 342K 2025-12
Pfizer USD 662M 5M 2026-09
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 222M 65M 2026-09
Takeda JPY 63.38B 466M 2026-09
Vanda Pharmaceuticals -1.37B 1.97B 2025-12